Verition Fund Management LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$4,115,191
+3.7%
397,6030.0%0.06%
-8.1%
Q4 2022$3,968,078
-0.5%
397,603
-50.0%
0.06%
+37.8%
Q3 2022$3,987,984
+0.8%
795,206
+100.0%
0.04%
-42.3%
Q2 2022$3,956,000
+0.7%
397,6030.0%0.08%
+66.0%
Q1 2022$3,928,000
-1.0%
397,6030.0%0.05%
+62.1%
Q4 2021$3,968,000
-0.2%
397,6030.0%0.03%
-14.7%
Q3 2021$3,976,000
-1.9%
397,603
-0.0%
0.03%
-8.1%
Q2 2021$4,052,000
-0.1%
397,6920.0%0.04%
-19.6%
Q1 2021$4,056,000397,6920.05%
Other shareholders

There were no reported owners of EUCRATES BIOMEDICAL ACQU COR in Q1 2022.

NameSharesValueWeighting ↓
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders